The influence of safety warnings on the prescribing of JAK inhibitors.
Russell, MD; Yang, Z; Walter, B; Alveyn, E; Bechman, K; Miracle, A; Nagra, D; Adas, MA; Norton, S; Cope, AP; +2 more...Langan, SM
; Galloway, JB and
(2024)
The influence of safety warnings on the prescribing of JAK inhibitors.
The Lancet. Rheumatology, 6 (3).
e138-e139.
ISSN 2665-9913
DOI: 10.1016/S2665-9913(24)00002-X
; Galloway, JB and
(2024)
The influence of safety warnings on the prescribing of JAK inhibitors.
The Lancet. Rheumatology, 6 (3).
e138-e139.
ISSN 2665-9913
DOI: 10.1016/S2665-9913(24)00002-X
-
picture_as_pdf - Russell-etal-2024-The-influence-of-safety-warnings-on-the-prescribing-of-JAK-inhibitors-supplement.pdf
-
subject - Accepted Version
-
error - This is an author accepted manuscript version of an article accepted for publication, and following peer review. Please be aware that minor differences may exist between this version and the final version if you wish to cite from it
-
- Available under Creative Commons: Attribution-NonCommercial-No Derivative Works 4.0
Downloads